Open MRI Systems Market by Component (Gradient Coils, Magnets, Power Supply Units), Field Strength (High Field Strength, Low Field Strength, Mid Field Strength), Imaging Mode, Application, End Users - Global Forecast 2025-2032
Description
The Open MRI Systems Market was valued at USD 1.64 billion in 2024 and is projected to grow to USD 1.77 billion in 2025, with a CAGR of 8.39%, reaching USD 3.12 billion by 2032.
How patient-centric engineering and ergonomic innovation are redefining open MRI systems to expand clinical adoption and operational utility
Open MRI systems are reshaping diagnostic imaging by improving patient comfort, expanding procedural flexibility, and enabling scanning in previously constrained clinical settings. Designed to reduce claustrophobia and accommodate diverse body types, these systems often include configurations that balance magnetic field geometry, radiofrequency design, and patient positioning to deliver clinically meaningful images while lowering barriers to utilization. As clinicians and administrators increasingly prioritize the patient experience, open architectures have moved from niche adoption toward mainstream consideration in outpatient, diagnostic center, and specialty clinic environments.
Technological progress in gradient coil design, radiofrequency systems, and magnet architectures has enabled better signal homogeneity and artifact control, narrowing the performance gap between open systems and traditional cylindrical scanners. Concurrently, manufacturer emphasis on ergonomic patient interfaces and streamlined workflows has reduced exam times and protocol complexity. This combination of patient-centric design and engineering refinement is fostering broader clinical acceptance, particularly for musculoskeletal, pediatric, and interventional applications where access and positioning matter. In short, open MRI systems are no longer merely an alternative for claustrophobic patients; they are evolving into practical tools that address specific clinical needs while supporting operational objectives.
Converging technological improvements and shifting care delivery priorities are driving open MRI innovation toward greater clinical versatility and operational efficiency
The landscape for open MRI systems is experiencing multiple transformative shifts driven by cross-disciplinary innovation, evolving clinical protocols, and changing care delivery models. Advances in gradient coil efficiency and radiofrequency chain optimization have improved image fidelity, enabling these scanners to address diagnostic questions once reserved for high-field cylindrical systems. Simultaneously, manufacturers are integrating software-driven reconstruction techniques and sequence improvements that compensate for lower field homogeneity, enhancing tissue contrast and quantitative output.
Operationally, there is a marked shift toward outpatient and ambulatory settings, where space constraints and patient turnover demand equipment that is compact, patient-friendly, and cost-effective to operate. The growth of value-based care and emphasis on throughput has increased demand for scanners that facilitate faster positioning and higher patient comfort, reducing repeat scans and improving patient satisfaction scores. Moreover, the convergence of therapeutic and diagnostic workflows-such as MRI-guided interventions and hybrid imaging suites-has elevated the importance of open designs that permit interventional access and real-time clinician engagement. Collectively, these trends are reshaping product roadmaps and procurement criteria, prompting suppliers to prioritize modularity, serviceability, and interoperability with hospital information and picture archiving systems.
Tariff-induced supply chain adjustments and procurement re-evaluations are reshaping sourcing decisions and equipment total cost considerations across healthcare providers
Recent tariff actions affecting medical equipment imports have introduced new complexities into procurement planning, supply chain structuring, and total cost of ownership assessments for imaging providers. Tariffs increase the effective landed cost of components and finished systems manufactured abroad, prompting health systems and group purchasing organizations to reassess sourcing strategies and supplier mixes. In response, some original equipment manufacturers have adjusted manufacturing footprints, prioritized regional sourcing, or restructured distribution agreements to mitigate tariff exposure and preserve price competitiveness.
Beyond direct cost implications, tariffs influence supplier decisions on product configuration and component localization. Manufacturers increasingly evaluate whether to re-balance production, substitute materials, or re-engineer assemblies to reduce reliance on tariff-affected suppliers. These operational shifts carry implications for lead times, spare-part availability, and long-term service contracts. For healthcare providers, the result is heightened demand for procurement teams to incorporate tariff scenario planning into capital budgets and to consider extended service agreements or refurbishment pathways as alternative cost management strategies. Overall, tariffs add a layer of strategic complexity that underscores the need for flexible sourcing and closer collaboration between clinical, procurement, and supplier stakeholders.
Integrated segmentation perspectives reveal where component advances and clinical requirements converge to determine open MRI system utility and procurement priorities
Analysis across component, field strength, imaging mode, application, and end-user dimensions reveals how product design and clinical needs intersect to shape adoption patterns. Based on Component, market is studied across Gradient Coils, Magnets, Power Supply Units, and Radio Frequency System, and this lens highlights that innovations in coils and RF architecture disproportionately influence perceived image quality and exam throughput. Improvements to gradient coil linearity and RF coil arrays have direct clinical impact, enhancing resolution in targeted anatomical studies and enabling more efficient pulse sequences. Based on Field Strength, market is studied across High Field Strength, Low Field Strength, and Mid Field Strength, and this classification underscores trade-offs between signal-to-noise performance and patient access; mid and low field systems frequently prioritize ergonomics and safety margins while tailoring protocols to clinical indications where extreme field strength is unnecessary.
Based on Imaging Mode, market is studied across 2D Imaging and 3D Imaging, illustrating that advances in three-dimensional acquisition and reconstruction broaden the clinical utility of open systems for musculoskeletal and neurological applications that benefit from volumetric datasets. Based on Application, market is studied across Breast Imaging, Cardiovascular Imaging, Neurological Imaging, and Spine & Musculoskeletal Imaging, which clarifies that each clinical domain imposes distinct requirements for coil design, contrast mechanisms, and motion compensation strategies. Lastly, Based on End Users, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, Hospitals, and Research Organizations, revealing that purchasing criteria diverge between high-throughput outpatient settings that prioritize speed and cost-efficiency versus research and tertiary centers that demand extensible platforms supporting advanced sequences and experimental coils. Together, these segmentation perspectives illuminate where incremental engineering gains and clinical workflow improvements will yield the greatest adoption upside.
Regional adoption is influenced by diverse regulatory, reimbursement, and infrastructure priorities that determine procurement choices and vendor go-to-market strategies
Regional dynamics are shaping adoption patterns, regulatory focus, and supplier strategies in distinctive ways. In the Americas, healthcare systems emphasize patient experience, outpatient capacity expansion, and consolidation among provider groups; these forces drive demand for scanners that deliver predictable workflows, straightforward serviceability, and compatibility with widely used electronic health record ecosystems. Manufacturers competing in this region increasingly offer local service networks and flexible financing models to align with health system capital cycles.
In Europe, Middle East & Africa, diverse regulatory frameworks and variable reimbursement environments create differentiated demand pockets. In some European markets, heightened regulatory scrutiny around safety and interoperability fosters demand for well-documented compliance and integration support. Middle Eastern markets often prioritize rapid access to advanced technologies for flagship hospitals, whereas several markets across Africa focus on robust, easily maintainable systems suitable for constrained infrastructure. Across the Asia-Pacific region, a mix of public and private investment is spurring expansion of diagnostic capacity; provider emphasis on scalable solutions and training partnerships is driving vendors to offer localized clinical education and modular product variants. These regional contrasts shape how vendors prioritize distribution, service investments, and partnerships with healthcare system stakeholders.
Competitive landscape highlights a balance between incumbent reliability and innovative entrants offering targeted technical differentiation and rapid software-driven enhancements
Competitive dynamics in the open MRI space reflect a mix of established imaging suppliers, specialized niche manufacturers, and emerging technology entrants. Incumbent firms leverage long-standing service networks, extensive clinical validation datasets, and broad portfolios that span coils, software suites, and service contracts. These organizations often compete on reliability, integration capabilities, and the breadth of clinical applications supported by their platforms. Conversely, specialized vendors focus on targeted performance attributes-such as enhanced open-bore ergonomics, lightweight magnet technologies, or sequence optimization-to capture specific clinical segments where access or patient comfort is a decisive factor.
Newer entrants and technology-focused teams bring rapid iteration to control electronics, reconstruction software, and user interface design, challenging incumbents to accelerate product roadmaps. Partnerships between equipment suppliers and third-party software developers are increasingly common, enabling advanced reconstruction, AI-assisted image enhancement, and workflow orchestration without deep changes to hardware. For providers, this competitive mix creates choices that balance long-term service commitments with the potential for near-term functional differentiation. Strategic purchasers will likely weigh vendor stability, regional service footprint, and the extensibility of software and coil ecosystems when selecting partners.
Practical strategic actions for manufacturers and providers to enhance system longevity, clinical relevance, and supply chain resilience in open MRI deployments
Leaders in manufacturing, clinical operations, and procurement should pursue a set of actionable initiatives to convert insight into tangible advantage. First, prioritize modular product roadmaps and service architectures that allow rapid field upgrades to coils and software, thereby protecting installed base value and reducing the need for full-system replacements. Second, strengthen regional service and parts networks to shorten repair cycles and ensure predictable uptime, which directly affects throughput and patient satisfaction. Third, embed tariff and supply-chain scenario planning into procurement cycles to preserve margin and avoid sudden disruptions; this includes cultivating multiple qualified suppliers for critical subassemblies and evaluating nearshoring or assembly localization where feasible.
Clinical leaders should accelerate validation studies that align open system capabilities with defined diagnostic pathways, particularly in musculoskeletal, pediatric, and interventional settings where patient access and comfort yield measurable clinical benefits. Finally, pursue partnerships with software innovators to integrate advanced reconstruction, AI-based image enhancement, and workflow orchestration tools, enabling providers to extract additional clinical value from existing hardware investments. Executing these steps will improve operational resilience, shorten time-to-value for new deployments, and better align product capabilities with evolving clinical use cases.
Transparent methodology combining technical dossier review, expert interviews, regulatory analysis, and cross-segmentation triangulation to ensure robust actionable insights
This analysis synthesizes technical literature, supplier product specifications, regulatory guidance, and structured interviews with clinical leaders, procurement specialists, and service managers to construct a balanced view of the open MRI landscape. Data inputs include device technical dossiers, peer-reviewed imaging methodology publications, and publicly available regulatory filings that document design attributes, safety considerations, and interoperability expectations. Qualitative insights derive from discussions with radiologists, MR technologists, and biomedical engineers to validate clinical priorities and to surface operational constraints that shape purchasing decisions.
Analytical methods emphasize cross-segmentation triangulation, assessing how component-level innovations interact with field strength choices, imaging modes, clinical applications, and end-user requirements. Regional analysis relies on policy documents, procurement frameworks, and direct engagement with distribution partners to identify logistical and regulatory differentiators. Wherever possible, assertions are corroborated against multiple independent sources and expert interviews to ensure robustness. The approach is intended to provide decision-useful intelligence while maintaining transparency about evidence sources and analytical boundaries.
Synthesis of clinical, technical, and operational factors that define the strategic role and practical value of open MRI systems in contemporary healthcare settings
Open MRI systems occupy an increasingly strategic position within modern imaging portfolios, offering distinctive advantages in patient access, procedural flexibility, and niche clinical use cases. Technological advances in coil design, RF subsystems, and reconstruction software have narrowed historical performance gaps, enabling these systems to address specific diagnostic needs with confidence. Regional and regulatory differences influence procurement rationales and service requirements, while tariff dynamics and supply chain considerations add an operational layer that organizations must actively manage.
For clinical and procurement leaders, the path forward is defined by pragmatic alignment of system capabilities with intended clinical workflows, rigorous validation of diagnostic performance for prioritized applications, and disciplined supply chain planning that mitigates cost and availability risks. When paired with strategic partnerships that extend software and service capabilities, open MRI systems can deliver measurable benefits in patient experience and operational flexibility. In conclusion, stakeholders that combine technical discernment with adaptive sourcing and clinical validation will realize the greatest value from investments in open MRI technologies.
Please Note: PDF & Excel + Online Access - 1 Year
How patient-centric engineering and ergonomic innovation are redefining open MRI systems to expand clinical adoption and operational utility
Open MRI systems are reshaping diagnostic imaging by improving patient comfort, expanding procedural flexibility, and enabling scanning in previously constrained clinical settings. Designed to reduce claustrophobia and accommodate diverse body types, these systems often include configurations that balance magnetic field geometry, radiofrequency design, and patient positioning to deliver clinically meaningful images while lowering barriers to utilization. As clinicians and administrators increasingly prioritize the patient experience, open architectures have moved from niche adoption toward mainstream consideration in outpatient, diagnostic center, and specialty clinic environments.
Technological progress in gradient coil design, radiofrequency systems, and magnet architectures has enabled better signal homogeneity and artifact control, narrowing the performance gap between open systems and traditional cylindrical scanners. Concurrently, manufacturer emphasis on ergonomic patient interfaces and streamlined workflows has reduced exam times and protocol complexity. This combination of patient-centric design and engineering refinement is fostering broader clinical acceptance, particularly for musculoskeletal, pediatric, and interventional applications where access and positioning matter. In short, open MRI systems are no longer merely an alternative for claustrophobic patients; they are evolving into practical tools that address specific clinical needs while supporting operational objectives.
Converging technological improvements and shifting care delivery priorities are driving open MRI innovation toward greater clinical versatility and operational efficiency
The landscape for open MRI systems is experiencing multiple transformative shifts driven by cross-disciplinary innovation, evolving clinical protocols, and changing care delivery models. Advances in gradient coil efficiency and radiofrequency chain optimization have improved image fidelity, enabling these scanners to address diagnostic questions once reserved for high-field cylindrical systems. Simultaneously, manufacturers are integrating software-driven reconstruction techniques and sequence improvements that compensate for lower field homogeneity, enhancing tissue contrast and quantitative output.
Operationally, there is a marked shift toward outpatient and ambulatory settings, where space constraints and patient turnover demand equipment that is compact, patient-friendly, and cost-effective to operate. The growth of value-based care and emphasis on throughput has increased demand for scanners that facilitate faster positioning and higher patient comfort, reducing repeat scans and improving patient satisfaction scores. Moreover, the convergence of therapeutic and diagnostic workflows-such as MRI-guided interventions and hybrid imaging suites-has elevated the importance of open designs that permit interventional access and real-time clinician engagement. Collectively, these trends are reshaping product roadmaps and procurement criteria, prompting suppliers to prioritize modularity, serviceability, and interoperability with hospital information and picture archiving systems.
Tariff-induced supply chain adjustments and procurement re-evaluations are reshaping sourcing decisions and equipment total cost considerations across healthcare providers
Recent tariff actions affecting medical equipment imports have introduced new complexities into procurement planning, supply chain structuring, and total cost of ownership assessments for imaging providers. Tariffs increase the effective landed cost of components and finished systems manufactured abroad, prompting health systems and group purchasing organizations to reassess sourcing strategies and supplier mixes. In response, some original equipment manufacturers have adjusted manufacturing footprints, prioritized regional sourcing, or restructured distribution agreements to mitigate tariff exposure and preserve price competitiveness.
Beyond direct cost implications, tariffs influence supplier decisions on product configuration and component localization. Manufacturers increasingly evaluate whether to re-balance production, substitute materials, or re-engineer assemblies to reduce reliance on tariff-affected suppliers. These operational shifts carry implications for lead times, spare-part availability, and long-term service contracts. For healthcare providers, the result is heightened demand for procurement teams to incorporate tariff scenario planning into capital budgets and to consider extended service agreements or refurbishment pathways as alternative cost management strategies. Overall, tariffs add a layer of strategic complexity that underscores the need for flexible sourcing and closer collaboration between clinical, procurement, and supplier stakeholders.
Integrated segmentation perspectives reveal where component advances and clinical requirements converge to determine open MRI system utility and procurement priorities
Analysis across component, field strength, imaging mode, application, and end-user dimensions reveals how product design and clinical needs intersect to shape adoption patterns. Based on Component, market is studied across Gradient Coils, Magnets, Power Supply Units, and Radio Frequency System, and this lens highlights that innovations in coils and RF architecture disproportionately influence perceived image quality and exam throughput. Improvements to gradient coil linearity and RF coil arrays have direct clinical impact, enhancing resolution in targeted anatomical studies and enabling more efficient pulse sequences. Based on Field Strength, market is studied across High Field Strength, Low Field Strength, and Mid Field Strength, and this classification underscores trade-offs between signal-to-noise performance and patient access; mid and low field systems frequently prioritize ergonomics and safety margins while tailoring protocols to clinical indications where extreme field strength is unnecessary.
Based on Imaging Mode, market is studied across 2D Imaging and 3D Imaging, illustrating that advances in three-dimensional acquisition and reconstruction broaden the clinical utility of open systems for musculoskeletal and neurological applications that benefit from volumetric datasets. Based on Application, market is studied across Breast Imaging, Cardiovascular Imaging, Neurological Imaging, and Spine & Musculoskeletal Imaging, which clarifies that each clinical domain imposes distinct requirements for coil design, contrast mechanisms, and motion compensation strategies. Lastly, Based on End Users, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, Hospitals, and Research Organizations, revealing that purchasing criteria diverge between high-throughput outpatient settings that prioritize speed and cost-efficiency versus research and tertiary centers that demand extensible platforms supporting advanced sequences and experimental coils. Together, these segmentation perspectives illuminate where incremental engineering gains and clinical workflow improvements will yield the greatest adoption upside.
Regional adoption is influenced by diverse regulatory, reimbursement, and infrastructure priorities that determine procurement choices and vendor go-to-market strategies
Regional dynamics are shaping adoption patterns, regulatory focus, and supplier strategies in distinctive ways. In the Americas, healthcare systems emphasize patient experience, outpatient capacity expansion, and consolidation among provider groups; these forces drive demand for scanners that deliver predictable workflows, straightforward serviceability, and compatibility with widely used electronic health record ecosystems. Manufacturers competing in this region increasingly offer local service networks and flexible financing models to align with health system capital cycles.
In Europe, Middle East & Africa, diverse regulatory frameworks and variable reimbursement environments create differentiated demand pockets. In some European markets, heightened regulatory scrutiny around safety and interoperability fosters demand for well-documented compliance and integration support. Middle Eastern markets often prioritize rapid access to advanced technologies for flagship hospitals, whereas several markets across Africa focus on robust, easily maintainable systems suitable for constrained infrastructure. Across the Asia-Pacific region, a mix of public and private investment is spurring expansion of diagnostic capacity; provider emphasis on scalable solutions and training partnerships is driving vendors to offer localized clinical education and modular product variants. These regional contrasts shape how vendors prioritize distribution, service investments, and partnerships with healthcare system stakeholders.
Competitive landscape highlights a balance between incumbent reliability and innovative entrants offering targeted technical differentiation and rapid software-driven enhancements
Competitive dynamics in the open MRI space reflect a mix of established imaging suppliers, specialized niche manufacturers, and emerging technology entrants. Incumbent firms leverage long-standing service networks, extensive clinical validation datasets, and broad portfolios that span coils, software suites, and service contracts. These organizations often compete on reliability, integration capabilities, and the breadth of clinical applications supported by their platforms. Conversely, specialized vendors focus on targeted performance attributes-such as enhanced open-bore ergonomics, lightweight magnet technologies, or sequence optimization-to capture specific clinical segments where access or patient comfort is a decisive factor.
Newer entrants and technology-focused teams bring rapid iteration to control electronics, reconstruction software, and user interface design, challenging incumbents to accelerate product roadmaps. Partnerships between equipment suppliers and third-party software developers are increasingly common, enabling advanced reconstruction, AI-assisted image enhancement, and workflow orchestration without deep changes to hardware. For providers, this competitive mix creates choices that balance long-term service commitments with the potential for near-term functional differentiation. Strategic purchasers will likely weigh vendor stability, regional service footprint, and the extensibility of software and coil ecosystems when selecting partners.
Practical strategic actions for manufacturers and providers to enhance system longevity, clinical relevance, and supply chain resilience in open MRI deployments
Leaders in manufacturing, clinical operations, and procurement should pursue a set of actionable initiatives to convert insight into tangible advantage. First, prioritize modular product roadmaps and service architectures that allow rapid field upgrades to coils and software, thereby protecting installed base value and reducing the need for full-system replacements. Second, strengthen regional service and parts networks to shorten repair cycles and ensure predictable uptime, which directly affects throughput and patient satisfaction. Third, embed tariff and supply-chain scenario planning into procurement cycles to preserve margin and avoid sudden disruptions; this includes cultivating multiple qualified suppliers for critical subassemblies and evaluating nearshoring or assembly localization where feasible.
Clinical leaders should accelerate validation studies that align open system capabilities with defined diagnostic pathways, particularly in musculoskeletal, pediatric, and interventional settings where patient access and comfort yield measurable clinical benefits. Finally, pursue partnerships with software innovators to integrate advanced reconstruction, AI-based image enhancement, and workflow orchestration tools, enabling providers to extract additional clinical value from existing hardware investments. Executing these steps will improve operational resilience, shorten time-to-value for new deployments, and better align product capabilities with evolving clinical use cases.
Transparent methodology combining technical dossier review, expert interviews, regulatory analysis, and cross-segmentation triangulation to ensure robust actionable insights
This analysis synthesizes technical literature, supplier product specifications, regulatory guidance, and structured interviews with clinical leaders, procurement specialists, and service managers to construct a balanced view of the open MRI landscape. Data inputs include device technical dossiers, peer-reviewed imaging methodology publications, and publicly available regulatory filings that document design attributes, safety considerations, and interoperability expectations. Qualitative insights derive from discussions with radiologists, MR technologists, and biomedical engineers to validate clinical priorities and to surface operational constraints that shape purchasing decisions.
Analytical methods emphasize cross-segmentation triangulation, assessing how component-level innovations interact with field strength choices, imaging modes, clinical applications, and end-user requirements. Regional analysis relies on policy documents, procurement frameworks, and direct engagement with distribution partners to identify logistical and regulatory differentiators. Wherever possible, assertions are corroborated against multiple independent sources and expert interviews to ensure robustness. The approach is intended to provide decision-useful intelligence while maintaining transparency about evidence sources and analytical boundaries.
Synthesis of clinical, technical, and operational factors that define the strategic role and practical value of open MRI systems in contemporary healthcare settings
Open MRI systems occupy an increasingly strategic position within modern imaging portfolios, offering distinctive advantages in patient access, procedural flexibility, and niche clinical use cases. Technological advances in coil design, RF subsystems, and reconstruction software have narrowed historical performance gaps, enabling these systems to address specific diagnostic needs with confidence. Regional and regulatory differences influence procurement rationales and service requirements, while tariff dynamics and supply chain considerations add an operational layer that organizations must actively manage.
For clinical and procurement leaders, the path forward is defined by pragmatic alignment of system capabilities with intended clinical workflows, rigorous validation of diagnostic performance for prioritized applications, and disciplined supply chain planning that mitigates cost and availability risks. When paired with strategic partnerships that extend software and service capabilities, open MRI systems can deliver measurable benefits in patient experience and operational flexibility. In conclusion, stakeholders that combine technical discernment with adaptive sourcing and clinical validation will realize the greatest value from investments in open MRI technologies.
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
182 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Integration of AI-driven imaging software enhancing open MRI diagnostic accuracy and patient throughput
- 5.2. Development of ultra-high-field open MRI systems for improved soft tissue contrast in musculoskeletal scans
- 5.3. Adoption of remote monitoring and tele-radiology capabilities for open MRI workflows in underserved regions
- 5.4. Implementation of noise reduction technologies to improve patient comfort during open MRI examinations
- 5.5. Strategic partnerships between open MRI manufacturers and cloud service providers for data interoperability
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Open MRI Systems Market, by Component
- 8.1. Gradient Coils
- 8.2. Magnets
- 8.3. Power Supply Units
- 8.4. Radio Frequency System
- 9. Open MRI Systems Market, by Field Strength
- 9.1. High Field Strength
- 9.2. Low Field Strength
- 9.3. Mid Field Strength
- 10. Open MRI Systems Market, by Imaging Mode
- 10.1. 2D Imaging
- 10.2. 3D Imaging
- 11. Open MRI Systems Market, by Application
- 11.1. Breast Imaging
- 11.2. Cardiovascular Imaging
- 11.3. Neurological Imaging
- 11.4. Spine & Musculoskeletal Imaging
- 12. Open MRI Systems Market, by End Users
- 12.1. Ambulatory Surgical Centers
- 12.2. Diagnostic Centers
- 12.3. Hospitals
- 12.4. Research Organizations
- 13. Open MRI Systems Market, by Region
- 13.1. Americas
- 13.1.1. North America
- 13.1.2. Latin America
- 13.2. Europe, Middle East & Africa
- 13.2.1. Europe
- 13.2.2. Middle East
- 13.2.3. Africa
- 13.3. Asia-Pacific
- 14. Open MRI Systems Market, by Group
- 14.1. ASEAN
- 14.2. GCC
- 14.3. European Union
- 14.4. BRICS
- 14.5. G7
- 14.6. NATO
- 15. Open MRI Systems Market, by Country
- 15.1. United States
- 15.2. Canada
- 15.3. Mexico
- 15.4. Brazil
- 15.5. United Kingdom
- 15.6. Germany
- 15.7. France
- 15.8. Russia
- 15.9. Italy
- 15.10. Spain
- 15.11. China
- 15.12. India
- 15.13. Japan
- 15.14. Australia
- 15.15. South Korea
- 16. Competitive Landscape
- 16.1. Market Share Analysis, 2024
- 16.2. FPNV Positioning Matrix, 2024
- 16.3. Competitive Analysis
- 16.3.1. Alliance Medical Systems
- 16.3.2. ASG Superconductors spa
- 16.3.3. Barco N.V.
- 16.3.4. Beijing Wandong Medical Technology Co.
- 16.3.5. Bruker Corporation
- 16.3.6. Canon Medical Systems Corporation
- 16.3.7. Esaote S.p.A
- 16.3.8. Fonar Corporation
- 16.3.9. FUJIFILM Holdings Corporation
- 16.3.10. GE HealthCare Technologies, Inc.
- 16.3.11. Hitachi Healthcare Manufacturing, Ltd.
- 16.3.12. Hologic, Inc.
- 16.3.13. Koninklijke Philips N.V.
- 16.3.14. Paramed Medical Systems, Inc.
- 16.3.15. Siemens AG
- 16.3.16. SternMed GmbH
- 16.3.17. VISION STAR PRIVATE LIMITED
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
